Advanced Medical Optics, Inc. (AMO) [NYSE:EYE]
today announced it will report second quarter 2007 financial results
before the market opens on Thursday, August 2, 2007.
The company will host a conference call and live web cast with investors
and analysts on Thursday, August 2, 2007, at 10:00am ET. To participate
in the live web cast or to access the archived replay, please visit AMO's
Investors site at http://www.amo-inc.com.
About Advanced Medical Optics (AMO)
AMO develops advanced, life-improving vision technologies for people of
all ages. Products in the cataract/implant line include intraocular
lenses (IOLs), phacoemulsification systems, viscoelastics, and related
products used in ocular surgery. AMO owns or has the rights to such
product brands as ReZoom®,
Tecnis®, Clariflex®,
Sensar®, and Verisyse®
IOLs, Sovereign®,
Sovereign® Compact
and WhiteStar Signature?
phacoemulsification systems with WhiteStar®
technology, Healon®
viscoelastics, and the Baerveldt®
glaucoma shunt. Products in the laser vision correction line include
wavefront diagnostic devices, femtosecond lasers and associated patient
interface devices, and excimer laser vision correction systems and
treatment cards. AMO brands in the laser vision correction business
include Star S4 IR®,
WaveScan Wavefront®,
CustomVue®,
IntraLase®
FS, IntraLase Method?
and IntraLasik®.
Products in the contact lens care line include disinfecting solutions,
enzymatic cleaners and lens rewetting drops. Among the eye care product
brands the company possesses are COMPLETE®,
COMPLETE®
Blink-N-Clean®,
Consept®F, Consept®
1 Step, Oxysept® 1
Step, UltraCare®,
Ultrazyme®, Total
Care? and blink?
branded products. AMO is based in Santa Ana, California, and employs
approximately 4,200 worldwide. The company has operations in 24
countries and markets products in approximately 60 countries. For more
information, visit the company's Website at www.amo-inc.com.
Advanced Medical Optics, Inc.
Investors:
Mark Levin,
714-247-8465
mark.levin@amo-inc.com
bourse
